-

Fifth Annual Best of Benchmark Award Winners Announced

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced the winners of the TGaS Best of Benchmark (BoBs) Awards. The Awards, which are given for operational excellence within the pharmaceutical industry, were presented to teams at Bayer, Genentech, Novo Nordisk, Sanofi, Sunovion and UCB. The BoBs are based on TGaS benchmarking of large, midsize and emerging life sciences companies.

While the specific BoB criteria subtly changes from function to function, the underlying factor for recognition is a pharma operations team that demonstrates the best capability relative to peers in the industry for a specific department, function or process. Winners are chosen based on TGaS benchmarks executed within the prior two calendar years, which gives the TGaS Division a deep understanding of all eligible clients.

“The operations leaders are often the ‘unsung heroes’ in the pharmaceutical organization,” said Gary McWalters, President, TGaS Advisors, a division of Trinity. “It’s an honor to recognize these deserving leaders and the winning companies for demonstrating superior capabilities that set them apart from their peer group. Congratulations to all the winners!”

Fifth Annual Best of Benchmark Award Winners:

Commercial Data Management: Data Strategy and Acquisition – Sanofi

Commercial Insights and Advanced Analytics: Insights and Analytics Integration – UCB

Field Operations: Field Analytics – Sunovion

Incentive Compensation Excellence: Incentive Compensation Innovation – Sanofi

Learning and Development: Onboarding Program – Bayer

Learning and Development: Emerging Leader Program – Sanofi

Marketing Operations: Department Capabilities – Novo Nordisk

Medical/Regulatory/Legal: Promotional Review Meeting Collaboration – Genentech

Omnichannel Marketing: Omnichannel Excellence – Novo Nordisk

Pricing, Contracting and Analytics: Government Programs – Genentech

About Trinity Life Sciences

Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With 25 years of experience, Trinity is committed to revolutionizing the commercial model by providing exceptional levels of service, powerful tools and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

Contacts

Media:
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

Trinity Life Sciences


Release Versions

Contacts

Media:
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

Social Media Profiles
More News From Trinity Life Sciences

Trinity Appoints Scott Evangelista as CEO to Lead Next Chapter

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a global leader in technology-enabled commercialization solutions for the life sciences industry, today announced Scott Evangelista has been appointed Chief Executive Officer, succeeding Leslie Orne who is stepping down after three years as CEO and over 24 years with the company. Ms. Orne will transition to the role of Senior Advisor and serve as a member of Trinity’s Board of Directors. Over her distinguished tenure, Ms. Orne helped guide Trinity’s evo...

GSK, Amgen and AstraZeneca Lead the Pack in Trinity’s 2025 Digital Marketing Competency Report

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization, today announced the release of its 5th Annual TGaS Digital Marketing Competency Report, a three-part series benchmarking the digital marketing presence of more than 150 biopharma brands. The 2025 edition reveals a significant leap forward in the industry’s digital sophistication, with a 19% increase in Proficient brands and a surge of innovation in patient engagement strategies. The report ranks each b...

Trinity Expands Global Footprint with Acquisition of EVERSANA’s APACME Advisory Services

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization solutions and recognized for being a strategic, tech-enabled commercialization company that empowers pharma, biotech, and medtech organizations to advance medical innovations, announced today the acquisition of EVERSANA’s advisory services operation in Asia-Pacific and the Middle East (APACME). The strategic acquisition will transition EVERSANA’s advisory services operation in APACME to Trinity, further...
Back to Newsroom